KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $4.1 billion.

  • Abbott Laboratories' Accounts Payables rose 220.62% to $4.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year increase of 220.62%. This contributed to the annual value of $4.2 billion for FY2024, which is 232.83% down from last year.
  • Latest data reveals that Abbott Laboratories reported Accounts Payables of $4.1 billion as of Q3 2025, which was up 220.62% from $4.3 billion recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Accounts Payables peaked at $4.8 billion during Q1 2022, and registered a low of $4.0 billion during Q3 2023.
  • Moreover, its 5-year median value for Accounts Payables was $4.2 billion (2024), whereas its average is $4.2 billion.
  • Per our database at Business Quant, Abbott Laboratories' Accounts Payables skyrocketed by 2782.14% in 2021 and then tumbled by 1240.28% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' Accounts Payables stood at $4.4 billion in 2021, then grew by 4.51% to $4.6 billion in 2022, then dropped by 6.77% to $4.3 billion in 2023, then fell by 2.33% to $4.2 billion in 2024, then decreased by 1.72% to $4.1 billion in 2025.
  • Its Accounts Payables stands at $4.1 billion for Q3 2025, versus $4.3 billion for Q2 2025 and $4.2 billion for Q1 2025.